(CAREstream America: Sanford, FL) -- CAREstream America, a leader in medical solution distribution for hospitals and aesthetics, announces an exclusive distribution partnership to bring Celltermi HS and NX Plus, an advanced probiotic-derived microbiome technology, to the U.S. market.

Celltermi HS and NX Plus represents a new chapter in science-driven topical solutions designed for today’s aesthetic skin and hair professionals. Developed using patented ingredients, Celltermi is supported by the scientific expertise and manufacturing capabilities of CHA Meditech, a subsidiary of CHA Bio Group, the globally recognized biomaterials pioneer with more than 65 years of experience.

This partnership combines CAREstream America’s commitment to delivering quality medical and aesthetic technologies with CHA Bio Group’s focus on innovation and research development.

CAREstream America to deliver a new standard of quality to the U.S. aesthetic market.

“In a rapidly evolving market, practitioners are seeking partners and products they can trust,” says Blake Petrunick, CEO of CAREstream America. “Our decision to partner with CHA Bio Group was driven by the strength of its foundation, patented technology, and commitment to rigorous standards. Practitioners deserve confidence in the products they bring into their practices, and we believe Celltermi represents the level of trust and quality that the market has been looking for.”

Unlike many products claiming space in this category, Celltermi synergy sets were developed with an emphasis on manufacturing integrity, scientific foundation, and ingredient quality. The serum sets leverage proprietary components produced with the support of an established South Korean biomaterials organization with a long history of advancing regenerative and health technologies.

“Our exclusive partnership with CAREstream America marks a significant milestone in bringing next-generation aesthetic solutions to the U.S. market,” says Sokjin Kim, CEO of CHA Meditech. “Celltermi is the culmination of decades of advanced cell research, leveraging our patented exosome and biomaterial technologies. By combining CAREstream’s robust distribution network with CHA’s deep-rooted scientific heritage, we are confident that we will establish a new standard of trust, quality, and efficacy for aesthetic professionals across the United States.”

The launch reflects a shared mission between the companies to elevate the standard for aesthetic solutions by prioritizing transparency, innovation, and scientifically grounded product development.

Celltermi HS and NX Plus are immediately available through CAREstream America for qualified providers and practices across the United States.